Sg Americas Securities, LLC Sorrento Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$0.74 - $1.83 $30,394 - $75,165	41,074 Added 76.46%	94,796 $84,000
Q3 2022 Oct 31, 2022	SELL	$1.51 - $2.88 $548,271 - $1.05 Million	-363,094 Reduced 87.11%	53,722 $84,000
Q2 2022 Jul 29, 2022	BUY	$1.24 - $2.33 $516,851 - $971,181	416,816 New	416,816 $838,000
Q1 2022 Apr 29, 2022	SELL	$2.0 - $4.9 $92,490 - $226,600	-46,245 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$4.65 - $7.23 $295,888 - $460,059	-63,632 Reduced 57.91%	46,245 $215,000
Q3 2021 Nov 01, 2021	BUY	$7.41 - $10.99 $720,252 - $1.07 Million	97,200 Added 766.74%	109,877 $838,000
Q2 2021 Aug 12, 2021	SELL	$6.35 - $10.0 $196,538 - $309,510	-30,951 Reduced 70.94%	12,677 $123,000
Q1 2021 May 13, 2021	BUY	$7.03 - $16.51 $143,643 - $337,348	20,433 Added 88.09%	43,628 $361,000
Q4 2020 Feb 04, 2021	SELL	$5.76 - $11.95 $617,904 - $1.28 Million	-107,275 Reduced 82.22%	23,195 $158,000
Q3 2020 Nov 09, 2020	BUY	$6.17 - $18.82 $564,110 - $1.72 Million	91,428 Added 234.18%	130,470 $1.46 Million
Q2 2020 Jul 20, 2020	SELL	$1.73 - $6.76 $11,080 - $43,297	-6,405 Reduced 14.09%	39,042 $245,000
Q1 2020 Apr 30, 2020	BUY	$1.57 - $4.76 $71,351 - $216,327	45,447 New	45,447 $84,000
Q4 2019 Jan 28, 2020	SELL	$1.45 - $4.17 $19,066 - $54,831	-13,149 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$2.05 - $2.69 $26,955 - $35,370	13,149 New	13,149 $28,000
Q4 2018 Feb 01, 2019	SELL	$2.01 - $4.24 $25,675 - $54,161	-12,774 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$4.22 - $7.5 $22,425 - $39,855	-5,314 Reduced 29.38%	12,774 $56,000
Q2 2018 Aug 07, 2018	BUY	$4.75 - $8.0 $85,918 - $144,704	18,088 New	18,088 $130,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account